03:39:56 EDT Mon 29 Apr 2024
Enter Symbol
or Name
USA
CA



Psybio Therapeutics Corp
Symbol PSYB
Shares Issued 83,926,793
Close 2023-11-24 C$ 0.01
Market Cap C$ 839,268
Recent Sedar Documents

Psybio Therapeutics downgraded to NEX

2024-03-25 17:33 ET - Symbol Change

In accordance with TSX Venture Exchange Policy 2.5, the company has not maintained the requirements for a TSX Venture Exchange Tier 2 company. Therefore, effective at the opening on Wednesday, March 27, 2024, the company's listing will transfer to the NEX, the company's tier classification will change from Tier 2 to the NEX, and the filing and service office will change from Toronto to the NEX.

As of March 27, 2024, the company is subject to restrictions on share issuances and certain types of payments as set out in the NEX policies.

The trading symbol for the company will change from PSYB to PSYB.H. There is no change in the company's name, no change in its Cusip number and no consolidation of capital. The symbol extension differentiates NEX symbols from Tier 1 or Tier 2 symbols within the TSX Venture Exchange market.

Further to the TSX Venture Exchange bulletin dated Dec. 6, 2023, trading in the shares of the company will remain suspended.

Members are prohibited from trading in the securities of the company during the period of the suspension or until further notice.

© 2024 Canjex Publishing Ltd. All rights reserved.